160 related articles for article (PubMed ID: 31608988)
1. Deoxyguanosine is a TLR7 agonist.
Davenne T; Bridgeman A; Rigby RE; Rehwinkel J
Eur J Immunol; 2020 Jan; 50(1):56-62. PubMed ID: 31608988
[TBL] [Abstract][Full Text] [Related]
2. Guanosine and its modified derivatives are endogenous ligands for TLR7.
Shibata T; Ohto U; Nomura S; Kibata K; Motoi Y; Zhang Y; Murakami Y; Fukui R; Ishimoto T; Sano S; Ito T; Shimizu T; Miyake K
Int Immunol; 2016 May; 28(5):211-22. PubMed ID: 26489884
[TBL] [Abstract][Full Text] [Related]
3. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
4. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
5. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7.
Lee J; Chuang TH; Redecke V; She L; Pitha PM; Carson DA; Raz E; Cottam HB
Proc Natl Acad Sci U S A; 2003 May; 100(11):6646-51. PubMed ID: 12738885
[TBL] [Abstract][Full Text] [Related]
7. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
Rajagopal D; Paturel C; Morel Y; Uematsu S; Akira S; Diebold SS
Blood; 2010 Mar; 115(10):1949-57. PubMed ID: 20065291
[TBL] [Abstract][Full Text] [Related]
9. Sustained IL-4 priming of macrophages enhances the inflammatory response to TLR7/8 ligand R848.
Banete A; Gee K; Basta S
J Leukoc Biol; 2022 Feb; 111(2):401-413. PubMed ID: 34013552
[TBL] [Abstract][Full Text] [Related]
10. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.
Heil F; Hemmi H; Hochrein H; Ampenberger F; Kirschning C; Akira S; Lipford G; Wagner H; Bauer S
Science; 2004 Mar; 303(5663):1526-9. PubMed ID: 14976262
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor kappaB (NF-kappaB) activation primes cells to a pro-inflammatory polarized response to a Toll-like receptor 7 (TLR7) agonist.
Lee J; Hayashi M; Lo JF; Fearns C; Chu WM; Luo Y; Xiang R; Chuang TH
Biochem J; 2009 Jun; 421(2):301-10. PubMed ID: 19426145
[TBL] [Abstract][Full Text] [Related]
12. IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells.
Sriram U; Xu J; Chain RW; Varghese L; Chakhtoura M; Bennett HL; Zoltick PW; Gallucci S
PLoS One; 2014; 9(1):e87668. PubMed ID: 24489947
[TBL] [Abstract][Full Text] [Related]
13. Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8.
Sarvestani ST; Tate MD; Moffat JM; Jacobi AM; Behlke MA; Miller AR; Beckham SA; McCoy CE; Chen W; Mintern JD; O'Keeffe M; John M; Williams BR; Gantier MP
J Virol; 2014 Jan; 88(2):799-810. PubMed ID: 24227841
[TBL] [Abstract][Full Text] [Related]
14. TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.
Kim H; Khanna V; Kucaba TA; Zhang W; Sehgal D; Ferguson DM; Griffith TS; Panyam J
Mol Pharm; 2020 Jun; 17(6):2109-2124. PubMed ID: 32383885
[TBL] [Abstract][Full Text] [Related]
15. Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.
Zhang Z; Ohto U; Shibata T; Krayukhina E; Taoka M; Yamauchi Y; Tanji H; Isobe T; Uchiyama S; Miyake K; Shimizu T
Immunity; 2016 Oct; 45(4):737-748. PubMed ID: 27742543
[TBL] [Abstract][Full Text] [Related]
16. Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist.
Carignan D; Herblot S; Laliberté-Gagné MÈ; Bolduc M; Duval M; Savard P; Leclerc D
Nanomedicine; 2018 Oct; 14(7):2317-2327. PubMed ID: 29128662
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of PEGylated toll like receptor 7 ligands.
Chan M; Hayashi T; Mathewson RD; Yao S; Gray C; Tawatao RI; Kalenian K; Zhang Y; Hayashi Y; Lao FS; Cottam HB; Carson DA
Bioconjug Chem; 2011 Mar; 22(3):445-54. PubMed ID: 21338093
[TBL] [Abstract][Full Text] [Related]
18. TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages.
Odoardi N; Kourko O; Petes C; Basta S; Gee K
J Innate Immun; 2021; 13(6):345-358. PubMed ID: 34058746
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization and genetic mapping of TLR7, TLR8a1 and TLR8a2 genes in rainbow trout (Oncorhynchus mykiss).
Palti Y; Gahr SA; Purcell MK; Hadidi S; Rexroad CE; Wiens GD
Dev Comp Immunol; 2010 Feb; 34(2):219-33. PubMed ID: 19825389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
